J&J Scraps Antipsychotic Study

[Guest guest]

http://online.wsj.com/article/SB10001424052748704559904576228742195359316.html?m\

od=rss_Health

March 28, 2011

 

J & J Scraps Antipsychotic Study

 

J & J has scrapped plans for a clinical trial comparing its injectable

antipsychotic Invega Sustenna with various oral treatments, citing a

" reconsideration of priorities. "

 

By Loftus

 

& has scrapped plans for a clinical trial comparing its

injectable antipsychotic Invega Sustenna with various oral treatments, citing a

" reconsideration of priorities. "

J & J, of New Brunswick, N.J., disclosed the development in an update last week to

a listing for the trial on the U.S. government database clinicaltrials.gov.

Patient enrollment hadn't started.

Sent via BlackBerry by AT & T

[Guest guest]

http://online.wsj.com/article/SB10001424052748704559904576228742195359316.html?m\

od=rss_Health

March 28, 2011

 

J & J Scraps Antipsychotic Study

 

J & J has scrapped plans for a clinical trial comparing its injectable

antipsychotic Invega Sustenna with various oral treatments, citing a

" reconsideration of priorities. "

 

By Loftus

 

& has scrapped plans for a clinical trial comparing its

injectable antipsychotic Invega Sustenna with various oral treatments, citing a

" reconsideration of priorities. "

J & J, of New Brunswick, N.J., disclosed the development in an update last week to

a listing for the trial on the U.S. government database clinicaltrials.gov.

Patient enrollment hadn't started.

Sent via BlackBerry by AT & T

[Guest guest]

http://online.wsj.com/article/SB10001424052748704559904576228742195359316.html?m\

od=rss_Health

March 28, 2011

 

J & J Scraps Antipsychotic Study

 

J & J has scrapped plans for a clinical trial comparing its injectable

antipsychotic Invega Sustenna with various oral treatments, citing a

" reconsideration of priorities. "

 

By Loftus

 

& has scrapped plans for a clinical trial comparing its

injectable antipsychotic Invega Sustenna with various oral treatments, citing a

" reconsideration of priorities. "

J & J, of New Brunswick, N.J., disclosed the development in an update last week to

a listing for the trial on the U.S. government database clinicaltrials.gov.

Patient enrollment hadn't started.

Sent via BlackBerry by AT & T

[Guest guest]

http://online.wsj.com/article/SB10001424052748704559904576228742195359316.html?m\

od=rss_Health

March 28, 2011

 

J & J Scraps Antipsychotic Study

 

J & J has scrapped plans for a clinical trial comparing its injectable

antipsychotic Invega Sustenna with various oral treatments, citing a

" reconsideration of priorities. "

 

By Loftus

 

& has scrapped plans for a clinical trial comparing its

injectable antipsychotic Invega Sustenna with various oral treatments, citing a

" reconsideration of priorities. "

J & J, of New Brunswick, N.J., disclosed the development in an update last week to

a listing for the trial on the U.S. government database clinicaltrials.gov.

Patient enrollment hadn't started.

Sent via BlackBerry by AT & T